Correlation Engine 2.0
Clear Search sequence regions


  • blood (6)
  • blood cells (1)
  • cytokines (1)
  • dna damage (2)
  • effects treatment (1)
  • help (1)
  • humans (1)
  • patient (1)
  • plasma (2)
  • plasma (3)
  • Sizes of these terms reflect their relevance to your search.

    Analysis of biomarkers in peripheral blood is becoming increasingly important in clinical trials to establish proof of mechanism to evaluate effects of treatment, and help guide dose and schedule setting of therapeutics. From a single blood draw, peripheral blood mononuclear cells can be isolated and processed to analyze and quantify protein markers, and plasma samples can be used for the analysis of circulating tumor DNA, cytokines, and plasma metabolomics. Longitudinal samples from a treatment provide information on the evolution of a given protein marker, the mutational status and immunological landscape of the patient. This can only be achieved if the processing of the peripheral blood is carried out effectively in clinical sites and samples are properly preserved from the bedside to bench. Here, we present an optimized general-purpose protocol that can be implemented at clinical sites for obtaining PBMC pellets and plasma samples in multi-center clinical trials, that will enable clinical professionals in hospital laboratories to successfully provide high quality samples, regardless of their level of technical expertise. Alternative protocol variations are also presented that are optimized for more specific downstream analytical methods. We apply this protocol for studying protein biomarkers against DNA damage response (DDR) on X-ray irradiated blood to demonstrate the suitability of the approach in oncology settings where DDR drugs and/or radiotherapy have been practiced as well as in preclinical stages where mechanistic hypothesis testing is required.

    Citation

    Paola Marco-Casanova, Natalia Lukashchuk, Benedetta Lombardi, Veerendra Munugalavadla, Melanie M Frigault, Elizabeth A Harrington, J Carl Barrett, Andrew J Pierce. Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis. Journal of visualized experiments : JoVE. 2021 Mar 20(169)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33818572

    View Full Text